2012
DOI: 10.3109/14653249.2012.690509
|View full text |Cite
|
Sign up to set email alerts
|

Processing of autologous bone marrow cells by apheresis technology for cell-based cardiovascular regeneration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 43 publications
0
3
0
Order By: Relevance
“…This process can take hours to complete. A labeless method of separating RBCs from stem cells that does not require the addition of sedimentation agents, that would not harm the stem cells, and that would be more rapid than the current method would be highly desirable (Basford, Forraz, Habibollah, Hanger, & McGuckin, 2010;Dettke et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…This process can take hours to complete. A labeless method of separating RBCs from stem cells that does not require the addition of sedimentation agents, that would not harm the stem cells, and that would be more rapid than the current method would be highly desirable (Basford, Forraz, Habibollah, Hanger, & McGuckin, 2010;Dettke et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…One of them is purifying biological samples from an excess of RBCs for diagnostic or therapeutic applications. For instance, isolation of RBCs form stem cells is desirable at bone marrow transplantation [249]. Additionally, it is known that blood transfusion may be associated with increased side effects due to the damage of RBCs after long storage [250,251].…”
Section: Magnetic Cell Separationmentioning
confidence: 99%
“…Various methods have been used for RBC depletion such as RBC sedimentation using Hydroxyethyl starch (HES) sedimentation or density gradientbased separation (DGBS) over Ficoll-Paque using COBE 2991 (Terumo BCT) [3] or not [4,5]. Studies have demonstrated feasibility and clinically efficiencies for centrifugation using automated or semi-automated separator devices such as Haemonetics Model 30 [6], Amicus (Fresenius-Kabi) and Fenwal CS3000 Omnix plus devices [7] or COBE Spectra [3,8,9], albeit with some quantitative variations between methods for RBC depletion and hematopoietic progenitor cells (HPC) recovery. The newly available BMP kit (Bone Marrow Program) available with the Spectra Optia device achieved results in a similar range as those reported for Optia's predecessor technology, the COBE Spectra [10][11][12][13].…”
Section: Introductionmentioning
confidence: 99%